MyAverix Finance
SHE · Healthcare
Tianjin Ringpu Bio Tech (300119)
Drug Manufacturers - Specialty & Generic
Tianjin Ringpu Bio Tech (300119) is listed on SHE in the Healthcare sector. Industry: Drug Manufacturers - Specialty & Generic. As of 2026-03-25, reported P/E ratio is 18.00. Use this page for a quick overview, then open the MyAverix Finance app for income statements, balance sheet, cash flow, and news.
Key metrics for 300119
Tianjin Ringpu Bio Tech (300119) — FAQ
What is 300119's P/E ratio?
The price-to-earnings (P/E) ratio for Tianjin Ringpu Bio Tech (300119) is 18.00 (data as of 2026-03-25).
Does Tianjin Ringpu Bio Tech pay a dividend?
Dividend yield is not available in the current snapshot for Tianjin Ringpu Bio Tech (300119). Check the MyAverix Finance app for the latest dividend data.
What sector is Tianjin Ringpu Bio Tech in?
Tianjin Ringpu Bio Tech (300119) is classified in the Healthcare sector (Drug Manufacturers - Specialty & Generic industry).
What exchange is 300119 listed on?
300119 is listed on SHE.
Full report in the app
Get the full report in the MyAverix Finance app — income, balance sheet, cash flow, ratios, and multi-year trends in one place.